Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Outpatient Dialysis Services Managers (US)

March 20, 2008
How Cancer Drug Affects Kidneys
By a GLG Expert Contributor
Analysis of: Doctors See How Cancer Drug Can Damage Kidneys (www.washingtonpost.com)
This article brings more visibility to issue of effect of angiogenesis inhibitors on kidney function Other mechanisms of injury have previously been described.  Current case simply adds visibility and more definitive evidence of effect in humans Mechanism described is likely not restricted...
May 11, 2007
Kidney Transplant Outcomes may improve with Rapamycin based Immunosupression
By a GLG Expert Contributor
Analysis of: Early Results Of The CellCept(R) Spare The Nephron Study Examine Kidney Function (www.medicalnewstoday.com)
Interim results from "Spare the Nephron Trial" demosntrate improved outcomes with Rapamycin based immunosupression compared with Calcinuerin based therapy.   If the results hold up the trial may precipitate a shift away from the use of cyclospoin and tacrolimus based therapy in favor...
May 11, 2007
Concern of Erythropoetin is Warranted
By a GLG Expert Contributor
Analysis of: US FDA staff cautious on anemia drugs' risks (www.therapeuticsdaily.com)
Results of recent studies have suggested that using erythropoetin to fully correct anemia in patients with chronic kidney disease or the use of Epo products in patients with cancer associated anemia is not associated with substantial clinical benefits and may actually increase the risk of...

Page : 11 to 3 of 3

Analytics


Generated at 2009-01-07T19:00:58.307